Related references
Note: Only part of the references are listed.Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Lawrence Fong et al.
CANCER DISCOVERY (2020)
Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response
Ben Sidders et al.
CLINICAL CANCER RESEARCH (2020)
Adenosine receptor blockade with ciforadenant +/- atezolizumab in advanced metastatic castration-resistant prostate cancer (mCRPC).
Lauren Christine Harshman et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma
Xiao-Lu Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
On the mechanism of anti-CD39 immune checkpoint therapy
David Allard et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity
Anna Wilk et al.
SCIENTIFIC REPORTS (2020)
CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection
Erik Wennerberg et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Control of Metastases via Myeloid CD39 and NK Cell Effector Function
Juming Yan et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Targeting an adenosine-mediated don't eat me signal augments anti-lymphoma immunity by anti-CD20 monoclonal antibody
Kyohei Nakamura et al.
LEUKEMIA (2020)
Blockade of Adenosine A2b Receptor Reduces Tumor Growth and Migration in Renal Cell Carcinoma
Ye Yi et al.
JOURNAL OF CANCER (2020)
Targeting the CD73-adenosine axis in immuno-oncology
David Allard et al.
IMMUNOLOGY LETTERS (2019)
Canonical and non-canonical adenosinergic pathways
E. Ferretti et al.
IMMUNOLOGY LETTERS (2019)
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy
Ryuma Tokunaga et al.
CLINICAL COLORECTAL CANCER (2019)
Specific Decrease in B-Cell-Derived Extracellular Vesicles Enhances Post-Chemotherapeutic CD8+ T Cell Responses
Fanghui Zhang et al.
IMMUNITY (2019)
The distinct role of CD73 in the progression of pancreatic cancer
Liangjing Zhou et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
ENTPD-1 disrupts inflammasome IL-1β-driven venous thrombosis
Vinita Yadav et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Immunobiology, preliminary safety, and efficacy of CPI-006, an anti-CD73 antibody with immune modulating activity, in a phase 1 trial in advanced cancers.
Jason J. Luke et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110 and predicts poor prognosis
Xiao-Lu Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
Ivan Perrot et al.
CELL REPORTS (2019)
Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis
Bertrand Allard et al.
ONCOIMMUNOLOGY (2019)
Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling
Linsen Shi et al.
MOLECULAR BIOLOGY OF THE CELL (2019)
Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells (vol 10, 162, 2019)
Claudia Sorrentino et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Selena Vigano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dysregulation of ectonucleotidase-mediated extracellular adenosine during postmenopausal bone loss
Yu-Ru Shih et al.
SCIENCE ADVANCES (2019)
The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
Harish Seethapathy et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
Xian-Yang Li et al.
CANCER DISCOVERY (2019)
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells
Beatris Mastelic-Gavillet et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer
Maarit K. Koivisto et al.
CARCINOGENESIS (2019)
Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1
Rosario Garcia-Rocha et al.
CYTOKINE (2019)
Adenosine Metabolism: Emerging Concepts for Cancer Therapy
Detlev Boison et al.
CANCER CELL (2019)
Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers
Lisa Seitz et al.
INVESTIGATIONAL NEW DRUGS (2019)
Mice lacking adenosine 2A receptor reveal increased severity of MCD-induced NASH
Jing Zhou et al.
JOURNAL OF ENDOCRINOLOGY (2019)
The adenosine A2B G protein-coupled receptor: Recent advances and therapeutic implications
Elizabeth A. Vecchio et al.
PHARMACOLOGY & THERAPEUTICS (2019)
EMT Transition States during Tumor Progression and Metastasis
Ievgenia Pastushenko et al.
TRENDS IN CELL BIOLOGY (2019)
Targeting the adenosine pathway for cancer immunotherapy
Akil Hammami et al.
SEMINARS IN IMMUNOLOGY (2019)
Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease
Mette D. Hazenberg et al.
BLOOD ADVANCES (2019)
Ectonucleotidases in Intestinal and Hepatic Inflammation
Marta Vuerich et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E
Yongbo Song et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2018)
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Ana Costa et al.
CANCER CELL (2018)
Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models
Robert D. Leone et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Adenosine receptors differentially regulate type 2 cytokine production by IL-33-activated bone marrow cells, ILC2s, and macrophages
Balazs Csoka et al.
FASEB JOURNAL (2018)
Adenosine A2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis
Aranzazu Mediero et al.
FASEB JOURNAL (2018)
Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity
Yuli Cai et al.
HEPATOLOGY (2018)
CD39-adenosinergic axis in renal pathophysiology and therapeutics
Bellamkonda K. Kishore et al.
PURINERGIC SIGNALLING (2018)
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
Limo Chen et al.
CANCER DISCOVERY (2018)
Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors
Sonja Hinz et al.
Oncotarget (2018)
CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
Michela Lupia et al.
STEM CELL REPORTS (2018)
Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Phase I/II study of the A2AR antagonist NIR178 (PBF-509), an oral immunotherapy, in patients (pts) with advanced NSCLC.
Alberto Chiappori et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells
Henrique Borges da Silva et al.
NATURE (2018)
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
Jie Lan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
Francesco Di Virgilio et al.
NATURE REVIEWS CANCER (2018)
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Arabella Young et al.
CANCER RESEARCH (2018)
Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial
L. Buisseret et al.
ANNALS OF ONCOLOGY (2018)
Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors
Baokun He et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Proximal Tubule CD73 Is Critical in Renal Ischemia-Reperfusion Injury Protection
Sun-sang J. Sung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
A2A adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity
Balazs Csoka et al.
FASEB JOURNAL (2017)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
The hypoxia-adenosine link during inflammation
Jessica L. Bowser et al.
JOURNAL OF APPLIED PHYSIOLOGY (2017)
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
Paul A. Beavis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
Silvana Morello et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
The adenosine A2b receptor promotes tumor progression of bladder urothelial carcinoma by enhancing MAPK signaling pathway
Yihong Zhou et al.
ONCOTARGET (2017)
Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review
Rong Wang et al.
ONCOTARGET (2017)
Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer
Yusuke Inoue et al.
ONCOTARGET (2017)
T Follicular Helper Cells Promote a Beneficial Gut Ecosystem for Host Metabolic Homeostasis by Sensing Microbiota-Derived Extracellular ATP
Lisa Perruzza et al.
CELL REPORTS (2017)
Purinergic Signaling in Mast Cell Degranulation and Asthma
Zhan-Guo Gao et al.
FRONTIERS IN PHARMACOLOGY (2017)
Targeting immunosuppressive adenosine in cancer (vol 17, pg 709, 2017)
Dipti Vijayan et al.
NATURE REVIEWS CANCER (2017)
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Tomasz Maj et al.
NATURE IMMUNOLOGY (2017)
CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy
Martin Turcotte et al.
CANCER RESEARCH (2017)
Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis
Arabella Young et al.
CANCER RESEARCH (2017)
MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
Julia Reinhardt et al.
CANCER RESEARCH (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
Bruno G. Leclerc et al.
CLINICAL CANCER RESEARCH (2016)
Loss of CD73-mediated actin polymerization promotes endometrial tumor progression
Jessica L. Bowser et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
Arabella Young et al.
CANCER CELL (2016)
Extracellular Adenosine Production by ecto-5′-Nucleotidase (CD73) Enhances Radiation-Induced Lung Fibrosis
Florian Wirsdoerfer et al.
CANCER RESEARCH (2016)
Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis
Deepak Mittal et al.
CANCER RESEARCH (2016)
The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias
Ajith A. Welihinda et al.
CELLULAR SIGNALLING (2016)
Beneficial Role of Erythrocyte Adenosine A2B Receptor-Mediated AMP-Activated Protein Kinase Activation in High-Altitude Hypoxia
Hong Liu et al.
CIRCULATION (2016)
Immunosuppressive activities of adenosine in cancer
Bertrand Allard et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
How does adenosine control neuronal dysfunction and neurodegeneration?
Rodrigo A. Cunha
JOURNAL OF NEUROCHEMISTRY (2016)
Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates With Progression of Human Myeloma
Alberto L. Horenstein et al.
MOLECULAR MEDICINE (2016)
Adenosine A2B receptors play an important role in bone homeostasis
Carmen Corciulo et al.
PURINERGIC SIGNALLING (2016)
Increased activity of TNAP compensates for reduced adenosine production and promotes ectopic calcification in the genetic disease ACDC
Hui Jin et al.
SCIENCE SIGNALING (2016)
MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma
Nathalie Bonnin et al.
ONCOTARGET (2016)
Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression
Claudia Sorrentino et al.
ONCOTARGET (2016)
Increased activity of TNAP compensates for reduced adenosine production and promotes ectopic calcification in the genetic disease ACDC
Hui Jin et al.
SCIENCE SIGNALING (2016)
Purinergic regulation of the immune system
Caglar Cekic et al.
NATURE REVIEWS IMMUNOLOGY (2016)
CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
Martin Turcotte et al.
CANCER RESEARCH (2015)
Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2
Aranzazu Mediero et al.
FASEB JOURNAL (2015)
Multi-Inhibitory Effects of A2A Adenosine Receptor Signaling on Neutrophil Adhesion Under Flow
Tadayuki Yago et al.
JOURNAL OF IMMUNOLOGY (2015)
IFN-γ Prevents Adenosine Receptor (A2bR) Upregulation To Sustain the Macrophage Activation Response
Heather B. Cohen et al.
JOURNAL OF IMMUNOLOGY (2015)
Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis
C. M. Aherne et al.
MUCOSAL IMMUNOLOGY (2015)
Expression of Adenosine Receptor Subclasses in Malignant and Adjacent Normal Human Prostate Tissues
Samira Mousavi et al.
PROSTATE (2015)
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Stephen M. Hatfield et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model
Claudia Sorrentino et al.
ONCOTARGET (2015)
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation
Fabio Morandi et al.
ONCOTARGET (2015)
The Proteomic Landscape of Triple-Negative Breast Cancer
Robert T. Lawrence et al.
CELL REPORTS (2015)
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses
Paul A. Beavis et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Adenosine receptors and renal ischaemia reperfusion injury
M. M. Rabadi et al.
ACTA PHYSIOLOGICA (2015)
A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability
Do-Geun Kim et al.
MOLECULAR NEUROBIOLOGY (2015)
Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis
J. Z. Zhou et al.
ONCOGENE (2015)
Extracellular adenosine regulates colitis through effects on lymphoid and nonlymphoid cells
Courtney C. Kurtz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment
Caglar Cekic et al.
CANCER RESEARCH (2014)
Adenosine A2A Receptors Intrinsically Regulate CD8+ T Cells in the Tumor Microenvironment
Caglar Cekic et al.
CANCER RESEARCH (2014)
Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
Deepak Mittal et al.
CANCER RESEARCH (2014)
NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer
Li Xiong et al.
CELL AND TISSUE RESEARCH (2014)
A2B Adenosine Receptor Induces Protective Antihelminth Type 2 Immune Responses
Nirav Patel et al.
CELL HOST & MICROBE (2014)
Human CD4+CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells
P. J. Schuler et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Adenosine A2A Receptor Antagonists in Parkinson's Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued
Annalisa Pinna
CNS DRUGS (2014)
The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor
Tian-zhu Liu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Anti-CD73 therapy impairs tumor angiogenesis
Bertrand Allard et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Role of TGF-β Signaling in Generation of CD39+CD73+ Myeloid Cells in Tumors
Sergey V. Ryzhov et al.
JOURNAL OF IMMUNOLOGY (2014)
Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
Stephen M. Hatfield et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Adenosine A2B receptor antagonist PSB603 suppresses tumor growth and metastasis by inhibiting induction of regulatory T cells
Wakako Kaji et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth
Melanie Mediavilla-Varela et al.
CANCER BIOLOGY & THERAPY (2013)
Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesis
Li Wang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
Bertrand Allard et al.
CLINICAL CANCER RESEARCH (2013)
Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
Yuting Ma et al.
IMMUNITY (2013)
Adenosine and cAMP signalling skew human dendritic cell differentiation towards a tolerogenic phenotype with defective CD8+ T-cell priming capacity
John Challier et al.
IMMUNOLOGY (2013)
The Adenosine-Dependent Angiogenic Switch of Macrophages to an M2-Like Phenotype is Independent of Interleukin-4 Receptor Alpha (IL-4Rα) Signaling
Christopher James Ferrante et al.
INFLAMMATION (2013)
Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis
Rebecca L. Williams-Karnesky et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Extracellular adenosine regulates naive T cell development and peripheral maintenance
Caglar Cekic et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Tissue-Nonspecific Alkaline Phosphatase Acts Redundantly with PAP and NT5E to Generate Adenosine in the Dorsal Spinal Cord
Sarah E. Street et al.
JOURNAL OF NEUROSCIENCE (2013)
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
Sherene Loi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors
Paul A. Beavis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis
Christophe J. Desmet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
An Adenosine-Mediated Signaling Pathway Suppresses Prenylation of the GTPase Rap1B and Promotes Cell Scattering
Elizabeth Ntantie et al.
SCIENCE SIGNALING (2013)
Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma
Raffaella Iannone et al.
NEOPLASIA (2013)
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
Alberto L. Horenstein et al.
ONCOIMMUNOLOGY (2013)
Increased CD39 expression on CD4+ T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia
Chava Perry et al.
ANNALS OF HEMATOLOGY (2012)
The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism
Silvia Garavaglia et al.
BIOCHEMICAL JOURNAL (2012)
NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity
H. Wang et al.
BRITISH JOURNAL OF CANCER (2012)
CD73-Deficient Mice Are Resistant to Carcinogenesis
John Stagg et al.
CANCER RESEARCH (2012)
Mechanisms of ATP release and signalling in the blood vessel wall
Alexander W. Lohman et al.
CARDIOVASCULAR RESEARCH (2012)
Adenosine promotes alternative macrophage activation via A2A and A2B receptors
Balazs Csoka et al.
FASEB JOURNAL (2012)
CD73-generated adenosine promotes osteoblast differentiation
Masahide Takedachi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
Caglar Cekic et al.
JOURNAL OF IMMUNOLOGY (2012)
Autocrine Adenosine Signaling Promotes Regulatory T Cell-Mediated Renal Protection
Gilbert R. Kinsey et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling
W. He et al.
PURINERGIC SIGNALLING (2012)
The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway
Akio Ohta et al.
FRONTIERS IN IMMUNOLOGY (2012)
Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells
Michael Romio et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Recent developments in adenosine receptor ligands and their potential as novel drugs
Christa E. Mueller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies
Catherine J. Wei et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
John Stagg et al.
CANCER RESEARCH (2011)
Generation of anti-inflammatory adenosine by leukocytes is regulated by TGF-β
Frederico S. Regateiro et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Altered purinergic signaling in CD73-deficient mice inhibits tumor progression
Gennady G. Yegutkin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
Long Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
Aled Clayton et al.
JOURNAL OF IMMUNOLOGY (2011)
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Sergey Ryzhov et al.
JOURNAL OF IMMUNOLOGY (2011)
Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
Noriaki Sunaga et al.
MOLECULAR CANCER THERAPEUTICS (2011)
NT5E Mutations and Arterial Calcifications
Cynthia St Hilaire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update
Bertil B. Fredholm et al.
PHARMACOLOGICAL REVIEWS (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease
Kori L. Wallace et al.
BLOOD (2010)
CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
Dachuan Jin et al.
CANCER RESEARCH (2010)
Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
Laetitia Aymeric et al.
CANCER RESEARCH (2010)
RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells
Xiuling Zhi et al.
CANCER SCIENCE (2010)
Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death
Leonora Himer et al.
FASEB JOURNAL (2010)
CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice
Xiaofeng Sun et al.
GASTROENTEROLOGY (2010)
Novel mechanism of signaling by CD28
Elisa Bjorgo et al.
IMMUNOLOGY LETTERS (2010)
Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Adenosine and Prostaglandin E2 Cooperate in the Suppression of Immune Responses Mediated by Adaptive Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Contribution of Adenosine A(2A) and A(2B) Receptors to Ischemic Coronary Dilation: Role of K-V and K-ATP Channels
Zachary C. Berwick et al.
MICROCIRCULATION (2010)
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
John Stagg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Central role of Sp1-regulated CD39 in hypoxia/ischemia protection
Holger K. Eltzschig et al.
BLOOD (2009)
Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer
Magis Mandapathil et al.
CLINICAL CANCER RESEARCH (2009)
Hypoxia-inducible Factor-Dependent Repression of Equilibrative Nucleoside Transporter 2 Attenuates Mucosal Inflammation During Intestinal Hypoxia
Julio C. Morote-Garcia et al.
GASTROENTEROLOGY (2009)
Adenosine regulates CD8 T-cell priming by inhibition of membrane-proximal T-cell receptor signalling
Carsten Linnemann et al.
IMMUNOLOGY (2009)
Adenosine signaling contributes to ethanol-induced fatty liver in mice
Zhongsheng Peng et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Differential regulation of HIF-1α isoforms in murine macrophages by TLR4 and adenosine A2A receptor agonists
Madhuri Ramanathan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Adenosine A2A receptor is a unique angiogenic target of HIF-2α in pulmonary endothelial cells
Aftab Ahmad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease
David J. Friedman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Tenascin C interacts with Ecto-5 '-nucleotidase (eN) and regulates adenosine generation in cancer cells
Rafal Sadej et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak
Julio C. Morote-Garcia et al.
BLOOD (2008)
Adenosine receptors in regulation of dendritic cell differentiation and function
Sergey V. Novitskiy et al.
BLOOD (2008)
Deletion of Cd39/Entpd1 results in hepatic insulin resistance
Keiichi Enjyoji et al.
DIABETES (2008)
Ecto-5′-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis
Zhongsheng Peng et al.
FASEB JOURNAL (2008)
Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function
Balazs Csoka et al.
FASEB JOURNAL (2008)
CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes
Masahide Takedachi et al.
JOURNAL OF IMMUNOLOGY (2008)
Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
Patrizia Pellegatti et al.
PLOS ONE (2008)
Host A2B adenosine receptors promote carcinoma growth
Sergey Ryzhov et al.
NEOPLASIA (2008)
A(2A) receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells
Paul E. Zarek et al.
BLOOD (2008)
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells:: hydrolysis of extracellular ATP and immune suppression
Giovanna Borsellino et al.
BLOOD (2007)
Adenosine, an endogenous distress signal, modulates tissue damage and repair
B. B. Fredholm
CELL DEATH AND DIFFERENTIATION (2007)
Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase a type I signaling
Tatiana Raskovalova et al.
CANCER RESEARCH (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors
Yu Chen et al.
SCIENCE (2006)
HIF-dependent induction of adenosine A2B receptor in hypoxia
Tianqing Kong et al.
FASEB JOURNAL (2006)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Adenosine A2A receptors play a role in the pathogenesis of hepatic cirrhosis
Edwin S. L. Chan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Adenosine-mediated inhibition of cytotoxic activity and cytokine production by IL-2/NKp46-activated NK cells - Involvement of protein kinase A isozyme I (PKA I)
Tatiana Raskovalova et al.
IMMUNOLOGIC RESEARCH (2006)
HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia
HK Eltzschig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
GS protein-coupled adenosine receptor signaling and lytic function of activated NK cells
T Raskovalova et al.
JOURNAL OF IMMUNOLOGY (2005)
Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1
A Desai et al.
MOLECULAR PHARMACOLOGY (2005)
A2A adenosine receptor induction inhibits IFN-γ production in murine CD4+ T cells
CM Lappas et al.
JOURNAL OF IMMUNOLOGY (2005)
Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors
S Minguet et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Role of estrogen receptor in the regulation of ecto-5′-nucleotidase and adenosine in breast cancer
J Spychala et al.
CLINICAL CANCER RESEARCH (2004)
Crucial role for ecto-5-′nucleotidase (CD73) in vascular leakage during hypoxia
LF Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes:: Role of cyclic adenosine 3',5'-monophosphate and phosphatases
H Zhang et al.
JOURNAL OF IMMUNOLOGY (2004)
Wnt and β-catenin signaling target the expression of ecto-5′-nucleotidase and increase extracellular adenosine generation
J Spychala et al.
EXPERIMENTAL CELL RESEARCH (2004)
The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis
J Mabley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells
GG Yegutkin et al.
BIOCHEMICAL JOURNAL (2002)
Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces
SH Donaldson et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Adenosine in the central nervous system: release mechanisms and extracellular concentrations
S Latini et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage
A Ohta et al.
NATURE (2001)
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor
B Johansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia
S Ibrahim et al.
BLOOD (2001)
CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism
L Airas et al.
JOURNAL OF IMMUNOLOGY (2000)
Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist
S Aoyama et al.
JOURNAL OF NEUROSCIENCE (2000)
Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock
G Haskó et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
